A Phase I, Open-Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of the Sumatriptan Iontophoretic Transdermal System in Adolescent Migraine Patients.
about
A Phase I, Open-Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of the Sumatriptan Iontophoretic Transdermal System in Adolescent Migraine Patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Phase I, Open-Label, Single- ...... Adolescent Migraine Patients.
@en
A Phase I, Open-Label, Single- ...... Adolescent Migraine Patients.
@nl
type
label
A Phase I, Open-Label, Single- ...... Adolescent Migraine Patients.
@en
A Phase I, Open-Label, Single- ...... Adolescent Migraine Patients.
@nl
prefLabel
A Phase I, Open-Label, Single- ...... Adolescent Migraine Patients.
@en
A Phase I, Open-Label, Single- ...... Adolescent Migraine Patients.
@nl
P2093
P2860
P356
P1433
P1476
A Phase I, Open-Label, Single- ...... Adolescent Migraine Patients.
@en
P2093
Dikla Gutman
Edward Hellriegel
Ernesto Aycardi
Helena Knebel
Jeevan Kunta
Mark Pierce
Ofer Spiegelstein
Orna Srur Kidron
Paul K Winner
Rohini Chitra
P2860
P304
P356
10.1111/HEAD.12895
P577
2016-07-29T00:00:00Z